mtc896
Small moleculeexperimental
Clinical trial activity
3 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
3
Phase 3
0
Phase 4
0
Earliest trial started Jul 1, 2010 (NCT01254162)
Timeline
Indications
Mechanism of action
- Melanocortin receptor 1INHIBITOR
MC1R inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- mtc896
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02395549 | Phase 2 | Apr 1, 2015 | Mimetica Pty Limited, Symbio |
| NCT02293018 | Phase 1/Phase 2 (Phase 2) | Aug 1, 2014 | Mimetica Pty Limited |
| NCT01254162 | Phase 2 | Jul 1, 2010 | Mimetica Pty Limited, TKL Research |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Mimetica Pty Limited | For profit | 3 | 3 | 1 | 2010 |
| Symbio | For profit | 1 | 0 | 1 | 2015 |
| TKL Research | For profit | 1 | 0 | 1 | 2010 |
3 organizations
Page 1 / 1